Nurse Practitioner, Family · Meridian, ID
NPI
1457848913
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
520 S Eagle Rd
Meridian, ID, 83642
Phone (208) 706-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
3,382 services
Medicare patients, 2024
169
Average age 66
Drug cost, 2024
$1.6M
2,900 prescriptions
Company payments, 2025
$21K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Parker was code 64615 (musculoskeletal), 155 times for 51 patients. In total Michael A Parker billed 3,382 services in 10 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 64615 Musculoskeletal | Facility | 155 | 51 | $68.05 | $11K |
| 99213 Office E&M - Established | Facility | 94 | 75 | $36.16 | $3,399 |
| 99214 Office E&M - Established | Facility | 60 | 52 | $55.59 | $3,335 |
By year: 2022 $19K for 1,969 services; 2023 $22K for 4,136 services; 2024 $22K for 3,382 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Parker prescribed most often to Medicare patients was Aimovig Autoinjector (Erenumab-Aooe), with 271 prescriptions and refills. In total Michael A Parker wrote 2,900 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aimovig Autoinjector Erenumab-Aooe | 271 | 307 | 49 | $224K |
| Emgality Pen Galcanezumab-Gnlm | 242 | 255 | 44 | $186K |
| Nurtec Odt Rimegepant Sulfate | 187 | 200 | 37 | $292K |
| Sumatriptan Succinate Generic | 152 | 169 | 37 | $8,974 |
| Naratriptan Hcl Generic | 148 | 161 | 35 | $9,301 |
| Qulipta Atogepant | 143 | 163 | 28 | $171K |
| Rizatriptan Rizatriptan Benzoate | 116 | 127 | 31 | $3,657 |
| Ubrelvy Ubrogepant | 115 | 124 | 28 | $141K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 112 | 144 | 24 | $102K |
| Gabapentin Generic | 96 | 215 | 29 | $2,865 |
| Topiramate Generic | 93 | 259 | 27 | $1,198 |
| Baclofen Generic | 53 | 95 | 17 | $3,098 |
| Levetiracetam Generic | 52 | 111 | 12 | $1,305 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 47 | 55 | Under 11 | $375 |
| Donepezil Hcl Generic | 44 | 80 | Under 11 | $375 |
Brand drugs: - claims; generic drugs: 1,707 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Parker $21K ($21K in general payments such as food, travel and fees) from 5 companies. The largest payer was Axsome Therapeutics, Inc. with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.